Skip to main content
Clinical Trials/NL-OMON45316
NL-OMON45316
Completed
N/A

Hemostasis in pediatric patients undergoing orthotopic liver transplantation: a prospective cohort study. - HIP-OLT

niversitair Medisch Centrum Groningen0 sites50 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
June 25, 2019
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Study group
  • \- Patients that undergo orthotopic liver transplantation for any reason at the UMCG, except patients with acute liver failure
  • \- Livers from all sort of donors will be included, including living donor livers
  • \- In the period from june 2017 to june 2018
  • \- Signed informed consent (patients and/or parents/guardian);Control group
  • \- Healthy patients that undergo minor surgery at the UMCG
  • Minor surgery includes inguinal operations and excision of soft tissue tumours other than malignancy, like a cyst, hemangioma or lipoma.
  • \- In the period from june 2017 to june 2018
  • \- Matched 2:1 with the study group population for age
  • \- Signed informed consent (patients and/or parents/guardian)

Exclusion Criteria

  • Study group
  • \- Age \> 16 years
  • \- No informed consent obtained
  • \- Diagnose of acute liver failure;Control group
  • \- Age \> 16 years
  • \- No informed consent obtained
  • \- Any comorbidities or pre\-term birth
  • \- Use of medication that influences liver function or hemostasis
  • \- History of thrombotic events or bleeding

Outcomes

Primary Outcomes

Not specified

Similar Trials